Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Thrombocytopenia 5Leukemia, Myeloid, Acute 3Myelodysplastic Syndromes 2Sarcoma 1Purpura, Thrombocytopenic, Idiopathic 1Myeloproliferative Disorders 1Leukemia 1Jacobs syndrome 1Healthy Adults 1

Interventions

eltrombopag 1adagrasib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Healthy Adults × eltrombopag × Clear all
NCT05924152 2024-03-13

A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib

Mirati Therapeutics Inc.

Phase 1 Completed
16 enrolled

Healthy Adults

Data powered by HemOnc (CC BY 4.0) Colophon âš¡